Chronic Obstructive Pulmonary Disease Archives - MPR

Chronic Obstructive Pulmonary Disease

Digital Health Tool Propeller Cleared for Use With Symbicort Inhaler

The Food and Drug Administration (FDA) has cleared the Propeller Health digital platform to connect with the Symbicort® Inhaler (budesonide, formoterol fumarate dihydrate; AstraZeneca), a corticosteroid and long-acting beta-2 agonist indicated for the treatment of asthma and COPD.  The Propeller platform includes a sensor that is attached to the inhaler. The sensor delivers insights on…